Kayatekin C, Amasino A, Gaglia G, et al. Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced Proteotoxicity. Cell. 2018;173(1):62-73.e9. doi:10.1016/j.cell.2018.02.026
Braga AL, de Meneses AAPM, Santos JV de, et al. Toxicogenetic study of omeprazole and the modulatory effects of retinol palmitate and ascorbic acid on Allium cepa. Chemosphere. 2018;204:220-226. doi:10.1016/j.chemosphere.2018.04.021
Lee JW, T Y Chan C, Slomovic S, Collins JJ. Next-generation biocontainment systems for engineered organisms. Nat Chem Biol. 2018;14(6):530-537. doi:10.1038/s41589-018-0056-x
Tian C, Huang Y, Clauser KR, et al. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells. Nat Commun. 2021;12(1):2328. doi:10.1038/s41467-021-22490-9
Grozinger CM, Chao ED, Blackwell HE, Moazed D, Schreiber SL. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem. 2001;276(42):38837-43. doi:10.1074/jbc.M106779200
Israelsen WJ, Dayton TL, Davidson SM, et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 2013;155(2):397-409. doi:10.1016/j.cell.2013.09.025
Chan K, Roberts SA, Klimczak LJ, et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet. 2015;47(9):1067-72. doi:10.1038/ng.3378
Kaufmann BB, Hung DT. The fast track to multidrug resistance. Mol Cell. 2010;37(3):297-8. doi:10.1016/j.molcel.2010.01.027
Kiani S, Chavez A, Tuttle M, et al. Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods. 2015;12(11):1051-4. doi:10.1038/nmeth.3580
Lindblad-Toh K, Wade CM, Mikkelsen TS, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 2005;438(7069):803-19. doi:10.1038/nature04338